Skip to main content

Advertisement

SpringerLink
Log in

Knockdown of TRAP1 promotes cisplatin-induced apoptosis by promoting the ROS-dependent mitochondrial dysfunction in lung cancer cells

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The tumor necrosis factor receptor-associated protein 1 (TRAP1) is associated with the occurrence and development of various diseases, including inflammation and cancer. However, the role and mechanism of TRAP1 in the development of lung cancer need to be further explored. Therefore, the purpose of this study is to investigate the role of TRAP1 in the regulation of apoptosis by cisplatin and its special mechanism. The RT-qPCR and Western blot were used to detect the mRNA and protein expression of ANGPTL4 in A549 and H1299 cells, respectively. And the cell apoptosis and cell cycle were measured by flow cytometry (FCM). The expression of genes related to apoptosis and drug resistance as well as the cell cycle regulators, including MDM2, CyclinB1, and CDK1, were detected by Western blot. Finally, the reactive oxygen species (ROS) indicator DCFH-DA was performed to detect the generation of ROS, and the mitochondrial membrane potential (ΔΨm) was detected by JC-1 staining. The results showed that the expression of TRAP1 was significantly increased in A549/DDP and H1299/DDP than A549 and H1299 cells. Further research found that knockdown of TRAP1 induced apoptosis and caused G2/M cell cycle arrest in A549/DDP and H1299/DDP cells. What is more, siTRAP1 reduced the relative JC-1 polymer monomer fluorescence ratio and decreased the ΔΨm, up-regulated the expression of Cytochrome C. Importantly, siTRAP1 induces ROS-dependent mitochondrial dysfunction. It is suggested that that TRAP1 suppresses cisplatin-induced apoptosis by promoting ROS-dependent mitochondrial dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Zhang Q, Yang J, Bai J, Ren J (2018) Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway. Cancer Sci 109(4):944–955

    Article  CAS  Google Scholar 

  2. Jiang K, Wang W, Jin X, Wang Z, Ji Z, Meng G (2015) Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells. Oncol Rep 33(6):2711–2718

    Article  CAS  Google Scholar 

  3. Qin LF, Ng IO (2002) Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett 175(1):27–38

    Article  CAS  Google Scholar 

  4. Shtivelman E, Hensing T, Simon GR, Dennis PA, Otterson GA, Bueno R et al (2014) Molecular pathways and therapeutic targets in lung cancer. Oncotarget 5(6):1392–1433

    Article  Google Scholar 

  5. Ruan Y, Hu K, Chen H (2015) Autophagy inhibition enhances isorhamnetininduced mitochondriadependent apoptosis in nonsmall cell lung cancer cells. Mol Med Rep 12(4):5796–5806

    Article  CAS  Google Scholar 

  6. Fulda S, Debatin KM (2006) Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25(34):4798–4811

    Article  CAS  Google Scholar 

  7. Zhao J, Wang SZ, Tang XF, Liu N, Zhao D, Mao ZY (2011) Analysis of thermochemotherapy-induced apoptosis and the protein expressions of Bcl-2 and Bax in maxillofacial squamous cell carcinomas. Med Oncol 28(1):354–359

    Article  CAS  Google Scholar 

  8. Suen DF, Norris KL, Youle RJ (2008) Mitochondrial dynamics and apoptosis. Genes Dev 22(12):1577–1590

    Article  CAS  Google Scholar 

  9. Xiang T, Du L, Pham P, Zhu B, Jiang S (2015) Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway. Cancer Lett 364(1):79–88

    Article  CAS  Google Scholar 

  10. Peng Z, Xia Y, Ji J, Chen W, Zhang J, Chen X et al (2016) Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer. Cancer Lett 375(1):114–126

    Article  Google Scholar 

  11. Speidel D (2010) Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20(1):14–24

    Article  CAS  Google Scholar 

  12. Li P, Zhao QL, Wu LH, Jawaid P, Jiao YF, Kadowaki M et al (2014) Isofraxidin, a potent reactive oxygen species (ROS) scavenger, protects human leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in p53-independent manner. Apoptosis 19(6):1043–1053

    Article  CAS  Google Scholar 

  13. Agorreta J, Hu J, Liu D, Delia D, Turley H, Ferguson DJ et al (2014) TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Mol Cancer Res 12(5):660–669

    Article  CAS  Google Scholar 

  14. Maddalena F, Sisinni L, Lettini G, Condelli V, Matassa DS, Piscazzi A et al (2013) Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1. Mol Oncol 7(5):895–906

    Article  CAS  Google Scholar 

  15. Cechetto JD, Gupta RS (2000) Immunoelectron microscopy provides evidence that tumor necrosis factor receptor-associated protein 1 (TRAP-1) is a mitochondrial protein which also localizes at specific extramitochondrial sites. Exp Cell Res 260(1):30–39

    Article  CAS  Google Scholar 

  16. Chen CF, Chen Y, Dai K, Chen PL, Riley DJ, Lee WH (1996) A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol 16(9):4691

    Article  CAS  Google Scholar 

  17. Sciacovelli M, Guzzo G, Morello V, Frezza C, Zheng L, Nannini N et al (2013) The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting succinate dehydrogenase. Cell Metab 17(6):988–999

    Article  CAS  Google Scholar 

  18. Yoshida S, Tsutsumi S, Muhlebach G, Sourbier C, Lee MJ, Lee S et al (2013) Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Pnas 110(17):E1604

    Article  CAS  Google Scholar 

  19. Chae YC, Angelin A, Lisanti S, Kossenkov AV, Speicher KD, Wang H et al (2013) Landscape of the mitochondrial Hsp90 metabolome in tumors. Nat Commun 4(2):2139

    Article  Google Scholar 

  20. Altieri DC, Stein GS, Lian JB, Languino LR (2012) TRAP-1, the mitochondrial Hsp90 ☆. Biochim Biophys Acta 1823(3):767

    Article  CAS  Google Scholar 

  21. Wang Q, Ren H, Xu Y, Jiang J, Wudu M, Liu Z et al (2020) GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the notch pathway. Exp Cell Res 387(2):111806

    Article  CAS  Google Scholar 

  22. Tada H, Tsuchiya R, Ichinose Y, Koike T, Nishizawa N, Nagai K et al (2004) A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 43(2):167–173

    Article  Google Scholar 

  23. Wang M, Li K, Zou Z, Li L, Zhu L, Wang Q et al (2018) Piperidine nitroxide Tempol enhances cisplatin-induced apoptosis in ovarian cancer cells. Oncol Lett 16(4):4847–4854

    PubMed  PubMed Central  Google Scholar 

  24. Ali BH, Moundhri MSA (2006) Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem Toxicol 44(8):1173–1183

    Article  CAS  Google Scholar 

  25. Agliarulo I, Matassa DS, Amoroso MR, Maddalena F, Sisinni L, Sepe L et al (2015) TRAP1 controls cell migration of cancer cells in metabolic stress conditions: correlations with AKT/p70S6K pathways. Biochim Biophys Acta 1853(10 Pt A):2570–2579

    Article  CAS  Google Scholar 

  26. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y (2001) Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance. Cancer Lett 168(2):173–181

    Article  CAS  Google Scholar 

  27. Leav I, Plescia J, Goel HL, Li J, Jiang Z, Cohen RJ et al (2010) Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol 176(1):393–401

    Article  CAS  Google Scholar 

  28. Klionsky DJ, Emr SD (2000) Autophagy as a regulated pathway of cellular degradation. Science 290(5497):1717–1721

    Article  CAS  Google Scholar 

  29. Glick D, Barth S, Macleod KF (2010) Autophagy: cellular and molecular mechanisms. J Pathol 221(1):3–12

    Article  CAS  Google Scholar 

  30. Rasul A, Bao R, Malhi M, Zhao B, Tsuji I, Li J et al (2013) Induction of apoptosis by costunolide in bladder cancer cells is mediated through ROS generation and mitochondrial dysfunction. Molecules 18(2):1418–1433

    Article  CAS  Google Scholar 

  31. Zeestraten ECM, Anne B, Reimers MS, Schouten PC, Liefers GJ, van de Velde CJH et al (2013) The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry. Biomarkers Cancer 5(5):13–29

    Google Scholar 

  32. Peng L, Zhao QL, Wu LH, Jawaid P, Jiao YF, Kadowaki M et al (2014) Isofraxidin, a potent reactive oxygen species (ROS) scavenger, protects human leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in p53-independent manner. Apoptosis 19(6):1043–1053

    Article  Google Scholar 

  33. Zhang P, Lu Y, Yu D, Zhang D, Hu W (2015) TRAP1 provides protection against myocardial ischemia-reperfusion injury by ameliorating mitochondrial dysfunction. Cell Physiol Biochem 36(5):2072–2082

    Article  CAS  Google Scholar 

  34. Chen JF, Wu QS, Xie YX, Si BL, Yang PP, Wang WY et al (2017) TRAP1 ameliorates renal tubulointerstitial fibrosis in mice with unilateral ureteral obstruction by protecting renal tubular epithelial cell mitochondria. FASEB J 31(10):4503

    Article  CAS  Google Scholar 

Download references

Funding

The research is supported by the Open Project Program of Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, People’s Republic of China(2019,no. KLTPM-SX2018-B4) and Xi’an Science & Technology plan (2019114613YX001SF034).

Author information

Authors and Affiliations

  1. Department of Oncology, Xi’an Central Hospital, The Affiliated Hospital of Xi’an Jiaotong University College of Medicine, Xi’an, 710003, Shaanxi, China

    Xiaowei Zhang

  2. Department of Respiratory, Xi’an Central Hospital, The Affiliated Hospital of Xian Jiaotong University College of Medicine, 185 Houzai Men, Xi’an, 710003, Shaanxi, China

    Yu Dong & Hua Guo

  3. Department of Obstetrics and Gynecology, Xi’an No.5 Hospital, Xi’an, 710082, Shaanxi, China

    Miao Gao

  4. Department of Neurology, Xi’an Central Hospital, The Affiliated Hospital of Xian Jiaotong University College of Medicine, Xi’an, 710003, Shaanxi, China

    Minfeng Hao

  5. Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China

    Hui Ren

  6. Yan’an University College of Medicine, Yan’an, 716000, Shaanxi, China

    Ling Guo

Authors
  1. Xiaowei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miao Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Minfeng Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ling Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hua Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hua Guo.

Ethics declarations

Conflict of interest

The authors declare no conflict of interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Dong, Y., Gao, M. et al. Knockdown of TRAP1 promotes cisplatin-induced apoptosis by promoting the ROS-dependent mitochondrial dysfunction in lung cancer cells. Mol Cell Biochem 476, 1075–1082 (2021). https://doi.org/10.1007/s11010-020-03973-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-020-03973-7

Keywords

Search

Navigation